Suppression of the interferon and NF-kb responses by Severe fever with thrombocytopenia syndrome virus

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8388-8401

  Qu, Bingqian ^a   Qi, Xian ^b   Wu, Xiaodong ^a   Liang, Mifang ^c   Li, Chuan ^c   Cardona, Carol J ^d   Xu, Wayne ^d   Tang, Fenyang ^b   Li, Zhifeng ^b   Wu, Bing ^b   Powell, Kira ^d   Wegner, Marta ^d   Li, Dexin ^c   Xing, Zheng ^a,d  

^a NANJING UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NUCLEOPROTEIN; PROTEIN KINASE; PROTEIN TBK1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

CELL LINE; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERON-BETA; MONOCYTES; NF-KAPPA B; PHLEBOVIRUS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84865063677     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00612-12     Document Type: Article

References (59)

1. Bachmann M, Moroy T. 2005. The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol. 37:726-730.
2. Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T. 1991. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc. Natl. Acad. Sci. U. S. A. 88: 10094-10098.
3. Bao CJ, et al. 2007. A family cluster of infections by a newly recognized bunyavirus in eastern China: further evidence of person-to-person transmission. Clin. Infect. Dis. 53:1208-1214.
4. Billecocq A, et al. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78: 9798-9806.
5. Bishop DH. 1986. Ambisense RNA genomes of arenaviruses and phleboviruses. Adv. Virus Res. 31:1-51.
6. Bishop DH. 1986. Ambisense RNA viruses: positive and negative polarities combined in RNA virus genomes. Microbiol. Sci. 3:183-187.
7. Bridgen A, Weber F, Fazakerley JK, Elliott RM. 2001. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:664-669.
8. Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B. 2005. C1 inhibitor: molecular and clinical aspects. Springer Semin. Immunopathol. 27:286-298.
9. Cotter CR, et al. 2011. The virion host shut-off (Vhs) protein of HSV-1 blocks the replication-independent activation of NF-kB in dendritic cells in the absence of type I interferon signaling. J. Virol. 85:12662-12672.
10. Dong H, Zhu G, Tamada K, Chen L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.
11. Flick R, Elgh F, Pettersson RF. 2002. Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance. J. Virol. 76:10849-10860.
12. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110 -S121.
13. Glynne R, et al. 1991. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357-360.
14. Habjan M, et al. 2009. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J. Virol. 83:4365-4375.
15. Hang do TT, Song JY, Kim MY, Park JW, Shin YK. 2011. Involvement of NF-kB in changes of IFN-γ-induced CIITA/MHC-II and iNOS expression by influenza virus in macrophages. Mol. Immunol. 48:1253-1262.
16. Heyninck K, Beyaert R. 1999. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kB activation at the level of TRAF6. FEBS Lett. 442:147-150.
17. Ikegami T, et al. 2009. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and posttranscriptional downregulation of protein kinase PKR. Ann. N. Y. Acad. Sci. 1171(Suppl 1):E75-E85.
18. Ikegami T, et al. 2009. Rift Valley fever virus NSs protein promotes posttranscriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog. 5:e1000287. doi:10.1371/ journal.ppat.1000287.
19. Jiao Y, et al. 2011. Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus (SFTSV) nucleocapsid protein for detection of total antibodies in human and animal sera by double antigen sandwich ELISA. J. Clin. Microbiol. 50:372-377.
20. Kalveram B, Lihoradova O, Ikegami T. 2011. NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J. Virol. 85:6234-6243.
21. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
22. Kelly A, et al. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353:667-668.
23. Kumar N, Xin ZT, Liang Y, Ly H. 2008. NF-kB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82:9880-9889.
24. Lappin D, Whaley K. 1989. Regulation of C1-inhibitor synthesis by interferons and other agents. Behring Inst. Mitt. 1989:180-192.
25. Le May N, et al. 2004. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541-550.
26. Le May N, et al. 2008. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus-infected cells. PLoS Pathog. 4:e13. doi:10.1371/ journal.ppat.0040013.
27. Leonard VH, Kohl A, Hart TJ, Elliott RM. 2006. Interaction of Bunyamwera orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J. Virol. 80:9667-9675.
28. Li DX. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 25:81-84. (In Chinese.)
29. Li J, Cardona CJ, Xing Z, Woolcock PR. 2008. Genetic and phenotypic characterization of a low-pathogenicity avian influenza H11N9 virus. Arch. Virol. 153:1899-1908.
30. Lu X, Pan J, Tao J, Guo D. 2011. SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42:37-45.
31. Minamoto S, et al. 1997. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237:79-83.
32. Nakitare GW, Elliott RM. 1993. Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm. Virology 195:511-520.
33. Opipari AW, Jr, Boguski MS, Dixit VM. 1990. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. 265:14705-14708.
34. Pomerantz JL, Baltimore D. 1999. NF-kB activation by a signaling complex containing TRAF2, TANK, and TBK1, a novel IKK-related kinase. EMBO J. 18:6694-6704.
35. Qi X, et al. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783.
36. Raymond DD, Piper ME, Gerrard SR, Smith JL. 2010. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation. Proc. Natl. Acad. Sci. U. S. A. 107:11769-11774.
37. Schmaljohn CH, et al. 2001. Bunyaviridae: the viruses and their replication, 4th ed. Lippincott Williams & Wilkin, Philadelphia, PA.
38. Schoggins JW, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
39. Simons JF, Persson R, Pettersson RF. 1992. Association of the nonstructural protein NSs of Uukuniemi virus with the 40S ribosomal subunit. J. Virol. 66:4233-4241.
40. Song HY, Rothe M, Goeddel DV. 1996. The tumor necrosis factorinducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kB activation. Proc. Natl. Acad. Sci. U. S. A. 93:6721-6725.
41. Streitenfeld H, et al. 2003. Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J. Virol. 77:5507-5511.
42. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75-86.
43. Thompson AJ, Locarnini SA. 2007. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol. 85:435-445.
44. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:3316-3326.
45. van Knippenberg I, Carlton-Smith C, Elliott RM. 2010. The N terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. J. Gen. Virol. 91:2002-2006.
46. Weber F, et al. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 76:7949-7955.
47. Weber F, Dunn EF, Bridgen A, Elliott RM. 2001. The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system. Virology 281:67-74.
48. Weber F, Haller O. 2007. Viral suppression of the interferon system. Biochimie 89:836-842.
49. Won S, Ikegami T, Peters CJ, Makino S. 2007. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J. Virol. 81:13335-13345.
50. Xing Z, et al. 2009. Differential regulation of antiviral and proinflammatory cytokines and suppression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages. J. Gen. Virol. 90: 1109-1118.
51. Xing Z, et al. 2008. Modulation of the immune responses in chickens by low-pathogenicity avian influenza virus H9N2. J. Gen. Virol. 89:1288-1299.
52. Xu F, et al. 2007. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am. J. Trop. Med. Hyg. 76:1194-1200.
53. Yadani FZ, Kohl A, Prehaud C, Billecocq A, Bouloy M. 1999. The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 73:5018-5025.
54. Yamazaki S, Muta T, Takeshige K. 2001. A novel IkB protein, IkB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kB in the nuclei. J. Biol. Chem. 276:27657-27662.
55. Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. 2007. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J. Virol. 81:2554-2563.
56. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65.
57. Yu XJ, et al. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364:1523-1532.
58. Zhang L, et al. 2008. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 300:2263-2270.
59. Zhang SQ, Kovalenko A, Cantarella G, Wallach D. 2000. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKK) upon receptor stimulation. Immunity 12:301-311.